期刊文献+

食管癌中MT-3基因mRNA的表达与含量差异性分析 被引量:6

The Differences Analysis of MT-3 mRNA Expression and Content in Esophageal Cancer
下载PDF
导出
摘要 目的探讨食管癌中MT-3基因mRNA的表达与含量差异性,为阐明食管癌发病机制提供参考。方法选择我院食管癌手术就诊者30例,取肿瘤中心及距肿瘤边缘至少5cm的食管切缘组织进行RT-PCR检测分析,检测对象为MT-3基因。结果 MT-3在食管癌组织中的表达量高于正常组织,同时不同病理分期与分化程度的食管癌组织中MT-3的表达量存在差异,分期越低,分化程度越好,其表达量越高。结论食管癌中MT-3基因mRNA的表达与正常组织表达存在差异,同时其表达受到病理分化程度与分期的影响。 Objective To investigate the differences of MT-3 mRNA expression and content in esophageal cancer for clarifying the mechanism of esophageal cancer. Methods Selected 30 cases with hospital surgical treatment of esophageal cancer,made the tumor center and at least 5 cm from the tumor margin of the esophagus peripheral tissues to analysis by RT-PCR, the detected object was MT-3 gene. Results The MT-3 expression in esophageal cancer tissues was higher than the normal tissue of the esophagus peripheral tissues. MT-3 expression were different in different phases of pathological staging of esophageal carcinoma, the expression was higher when the staging was lower;and different degrees of esophageal carcinoma in the MT-3 expression levels were different, the expression was higher when the degree of differentiation was better. Conclusions MT-3 mRNA expression in the esophageal cancer is different to the normal tissue expression, while its expression is affected by pathologic differentiation and stage.
作者 李勇强 王智
出处 《成都医学院学报》 CAS 2012年第2期217-219,共3页 Journal of Chengdu Medical College
关键词 食管癌 MT-3基因 RT—PCR 表达差异性 Esophageal cancer MT-3 gene RT-PCR Express differences
  • 相关文献

参考文献11

二级参考文献68

  • 1李超霞,吴名耀.慢性食管炎和食管癌旁粘膜上皮癌基因蛋白表达的比较[J].癌变.畸变.突变,2004,16(6):332-334. 被引量:4
  • 2霍霞,许险峰,徐锡金,林懿,杨海伟.抑癌基因PTEN在食管癌中的表达[J].中国组织化学与细胞化学杂志,2003,12(4):339-343. 被引量:8
  • 3李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 4李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 5[1]Dolan M E, Schilsky R L. Silence is golden: gene hypermethylation and survival in large-cell lymphoma. J National Cancer Institute, 2002, 94(1): 6
  • 6[2]Pegg A. Repair of O6-alkylguainne by alkyltransferases. Mutat. Res , 2000, 462(2-3): 82
  • 7[3]Bearzatto A, Szadkowski M, Macpherson P, et al. Epgenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents. Cancer Res, 2000, 60(12):3262
  • 8[4]Biswas T, Damana C V, Sriniavasan G, et al. Activation of human O6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone. Ocogene, 1999, 18(2):525
  • 9[5]Costello F J, Plass C. Methylation matters. J Med Genet, 2001, 38(5):285
  • 10[6]Suzuki H, Gabrielson E, Chen W, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet, 2002, 31(2):141

共引文献365

同被引文献58

  • 1单探幽,冯笑山,高社干,曲智锋,王战会,张洛,韩晶.多种肿瘤标志物对食管癌转移的检测及预后评估[J].临床肿瘤学杂志,2007,12(7):512-513. 被引量:5
  • 2Bamba T,Kosugi S, Takeuchi M, et al. Surveillance and treatment for second primary cancer in the gastric tube after radical esoplaagectomy[J]. Surgical Endoscopy, 2010,24(6) : 1310-1317.
  • 3Thomson IG, Smithers BM, Gotley DC, et al. Thoraco- scopic-assisted esophageetomy for esophageal cancer z analysis of patterns and prognostie factors for recur- rence[J]. Annals of Surgery,2010,252(2) :281-291.
  • 4Lagergren J. Adenocarcinoma of oesophagus:what ex- actly is the size of the problem and who is at risk [J]. Gut,2005,54(Suppl 1) .. 1-5.
  • 5Bennermo M, Held C, Stemme S, et al. Genetic predis- position of the interleukin-6 response to inflammation: implications for a variety of major diseases [J]. Clin Chem,2004,50(11) :2136-2140.
  • 6Kayaba H. Tumor markers: essential diagnostic tools for radiologists [J]. Nippon Lgaku Hoshasen Gakkai Zasshi,2003,63(4) : 133-139.
  • 7Skagauchi S, Yoknkwaa Y, Hou J, et al. Environmental exposure and p53 mutations in esophageal cancer patients in areas of low and high incidence of esophageal cancer in China[J]. Tohoku J ExpMed, 2005, 207(4): 313-314.
  • 8Deng D, EI-Rithi W, Ji J, et al. Hypermethylation of metallothionein-3 CpG island in gastric carcinoma [J]. Carcino- genesis, 2003, 24(1): 25-29.
  • 9Sens MA, Somji S, Garrett SH, et am. Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis[J]. AmJ Pathol, 2001, 159 (1): 21-26.
  • 10Erie S, Paul AD, Zi QT, et al. Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation[J]. Mol Cancer, 2005, 13 (4): 42.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部